摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]-N-[3-methyl-4-(tetrazol-1-yl)phenyl]prop-2-ynamide | 1401089-21-1

中文名称
——
中文别名
——
英文名称
N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]-N-[3-methyl-4-(tetrazol-1-yl)phenyl]prop-2-ynamide
英文别名
——
N-[2-(cyclopentylamino)-2-oxo-1-pyridin-3-ylethyl]-N-[3-methyl-4-(tetrazol-1-yl)phenyl]prop-2-ynamide化学式
CAS
1401089-21-1
化学式
C23H23N7O2
mdl
——
分子量
429.481
InChiKey
QSPBVALXLDSEPL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    106
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon
    申请人:NEAMATI Nouri
    公开号:US20130071328A1
    公开(公告)日:2013-03-21
    This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxicity in cancer cells and are useful as lead compounds for anti-cancer drugs or pharmaceutical agents. This invention also discloses treatment methods that uses the PACMAs and pharmaceutical compositions as well as methods for promoting the release and nuclear localization of the transcription factor Nrf2.
  • [EN] PROPYNOIC ACID CARBAMOYL METHYL-ALMIDES AND PHARMACEUTICAL COMPOSITIONS AND METHODS BASED THEREON<br/>[FR] CARBAMOYL MÉTHYL-AMIDES D'ACIDE PROPYNOÏQUE ET COMPOSITIONS PHARMACEUTIQUES ET PROCÉDÉS À BASE DE CEUX-CI
    申请人:UNIV SOUTHERN CALIFORNIA
    公开号:WO2012129452A2
    公开(公告)日:2012-09-27
    This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxicity in cancer cells and are useful as lead compounds for anti-cancer drugs or pharmaceutical agents. This invention also discloses treatment methods that uses the PACMAs and pharmaceutical compositions as well as methods for promoting the release and nuclear localization of the transcription factor Nrf2.
查看更多